GENERAL ATLANTIC, L.P. purchased 2.0% of their position (83K shares) of CINCOR PHARMA, INC. on the open market
Open‑market purchase worth $2.49M — a small addition. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 8/15/2022ACC: 0000950142-22-002525
10% Owner
Since Jan 2022
+83K
Net shares
Net buyer
$2.49M
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
83K acquired
Non-Derivative Transactions1
Common Stock, par value $0.00001 per share ("Common Stock")
Indirect
Shares
+83K
Price / share
$30.00
Trade value
$2.49M
% of position
2.0%
8/11/2022
4.13M→4.21M
Total
Net shares
+83K
Net value
$2.49M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.00001 per share ("Common Stock") Indirect | 8/11/2022 | P · Purchase | +83K | $30.00 | $2.49M | 2.0% | 4.13M | 4.21M |
| Total | +83K | $2.49M | ||||||
Derivative Transactions0
No derivative transactions reported